Clinical Trials

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05834348 2025-03-30

DELINOR

Completed

5,279 enrolled 10 charts

GastrointestinalGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung

NCT02876510 2025-02-04

ACTolog

Phase 1 Completed

38 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT03191786 2024-10-23

IPSOS

453 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung

NCT03526900 2024-10-09

ATEZO-BRAIN

40 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT02927301 2024-09-19

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

181 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT04194203 2024-07-19

A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

305 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04480372 2024-07-01

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Other solid neoplasmThoracic

68 enrolled

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT04426825 2024-05-21

A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer

23 enrolled 23 charts

Carcinoma, Non-Small-Cell Lung

NCT03976518 2024-03-01

CHANCE

43 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03511391 2024-01-23

CHEERS

DermatologicGenitourinaryHead & NeckThoracic

99 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Melanoma

NCT02716038 2023-12-12

Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

39 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT02657434 2023-11-21

A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)

578 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT02994576 2023-09-29

PRINCEPS

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03559647 2023-09-01

The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy

Completed

358 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03102242 2023-05-24

Atezolizumab Immunotherapy in Patients With Advanced NSCLC

64 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT04059887 2023-02-08

BUDDY

Phase 4 Completed

100 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02813785 2023-01-10

IMpower210

565 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03922997 2022-09-09

A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

101 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03438318 2022-08-03

Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer

Phase 1 Completed

29 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03790397 2022-06-03

OSIREX

Completed

169 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03801304 2022-05-12

VinMetAtezo

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02013219 2020-04-21

A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Completed

52 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02031458 2020-01-06

BIRCH

667 enrolled 29 charts

Carcinoma, Non-Small-Cell Lung

NCT03023423 2019-11-20

DARZALEX

Phase 1/2 Completed

100 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung

NCT01903993 2019-10-02

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

287 enrolled 15 charts

Phase EARLY_PHASE1 Completed

Carcinoma, Non-Small-Cell Lung

NCT02463994 2019-02-08

A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC

12 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01846416 2019-01-08

A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]

138 enrolled 21 charts